Product Information

IRBESARTAN 75 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0827 per EA under NDC 29300021213. Its NADAC has been published 121 times since Jan 31, 2024.

FDA first approved this application on Dec 7, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IRBESARTAN 75 MG TABLET

Irbesartan
$0.0827per EA

Strength

75 mg/1

NDC

29300021213

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IRBESARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA203020

FDA Approved

12/7/2015

TE Code

AB

On Market Since

12/7/2015

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for IRBESARTAN 75 MG TABLET has been published 121 times since Jan 31, 2024, and over the history we have for it it has declined 41.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0827 per EA
All-time high$0.1509 (Oct 16, 2024)
All-time low$0.0800 (May 20, 2026)
52-week high$0.1074
52-week low$0.0800
Median price$0.1117
Average price$0.1092
Largest weekly change-20.7% (Nov 20, 2024)
Weeks tracked121
Tracking sinceJan 31, 2024

Price History

1W

+2.7%

1M

+2.7%

3M

+3.3%

6M

-7.4%

1Y

-23.0%

3Y

N/A

5Y

N/A

All

-41.4%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of IRBESARTAN 75 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 75 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0827 per EA (NDC 29300021213), effective Aug 19, 2026.

How has the price of IRBESARTAN 75 MG TABLET changed over time?

Over the history we have for it, the NADAC for IRBESARTAN 75 MG TABLET has declined 41.4%. It has been tracked across 121 weekly CMS publications since Jan 31, 2024.

What are the highest and lowest recorded NADAC prices for IRBESARTAN 75 MG TABLET?

Since Jan 31, 2024, the NADAC for IRBESARTAN 75 MG TABLET has ranged from a low of $0.0800 (May 20, 2026) to a high of $0.1509 (Oct 16, 2024), with a median of $0.1117 per EA.

Are there cheaper alternatives to IRBESARTAN 75 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IRBESARTAN 75 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures IRBESARTAN 75 MG TABLET?

IRBESARTAN 75 MG TABLET (NDC 29300021213) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.